This country profile provides an overview of Rwanda’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Rwanda does not require mass treatment for elephantiasis.
Rwanda does not require mass treatment for blinding trachoma.
Treatment coverage remained at 99% in 2018 and 2019.
Treatment coverage decreased from 73% in 2018 to 70% in 2019.
Rwanda does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Rwanda.